Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
Erridge
Sara C
SC
University of Edinburgh and Edinburgh Centre for Neuro-Oncology, Edinburgh, UK. serridge@staffmail.ed.ac.uk
Gregor
Anna
A
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000556:secondary; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide